XXXX -induced release of excitatory amino acids in the skin of the @entity35 hindpaw.

@entity32 @entity2227 @entity1931 @entity406 @entity492 @entity143 @entity158 @entity35
Application of @entity2227 to skin evokes @entity158 [S.M. Carlton, G.L. Hargett, R.E. Coggeshall, Localization and activation of @entity2227 receptors in unmyelinated axons of @entity35 glabrous skin, Neurosci. Lett., 197 (1995) 25-28; D.L. Jackson, C.B. Graff, J.D. Richardson, K.M. Hargreaves, @entity2227 participates in the peripheral modulation of thermal @entity1931 in @entity35 , Eur. J. Pharmacol., 284 (1995) 321-325.] and peripherally-administered @entity2227 antagonists can prevent the nociception produced by @entity32 [E.M. Davidson, R.E. Coggeshall, S.M. Carlton, Peripheral @entity143 and non-NMDA @entity2227 receptors contribute to nociceptive behaviors in the @entity35 @entity406 test, NeuroReport, 8 (1997) 941-946; Jackson et al., 1995.] In this study, the concentrations of @entity2227 and @entity492 in the plantar of the @entity35 hindpaws were measured before and after the subcutaneous administration of @entity406 . Increases in @entity2227 and @entity492 concentrations were observed on the ipsilateral side, but not on the contralateral side, to the injection. This shows that nociception and @entity32 caused by @entity406 injection induces the release of peripheral @entity2227 and @entity492 , which would contribute to nociception and @entity158 .
